Publications by authors named "Sarah Jupp"
J Thromb Thrombolysis
August 2024
Article Synopsis
- Enoxaparin, a medication used to treat blood clots, is dosed based on actual body weight, but its effectiveness can vary in obese patients due to distribution differences related to body composition.
- The study evaluated dosing strategies and monitored Antifactor Xa (AFXa) levels in obese patients receiving enoxaparin, reviewing data from 762 patients over a year.
- Results showed no significant link between dosing and AFXa levels, and the rates of treatment failure (2.2%) and bleeding (5%) were comparable to general expectations, indicating that obesity did not independently impact treatment outcomes.
